| |
| |
|
| Insider
Information: |
Keyser D Jeffrey |
| Relationship: |
Director |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
41,927 |
|
|
Indirect Shares
|
48,744 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,671 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Encysive Pharmaceuticals Inc |
ENCY |
V.P., Regulatory Affairs |
2008-04-01 |
0 |
|
0 |
Premium* |
|
|
Zs Pharma, Inc. |
ZSPH |
Chief Operating Officer |
2015-12-17 |
0 |
2014-06-23 |
48,744 |
Premium* |
|
|
Lantern Pharma Inc. |
LTRN |
Director |
2020-06-15 |
41,927 |
2020-06-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LTRN |
Lantern Pharma Inc. |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,927 |
41,927 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
Director |
– • – |
2020-06-11 |
4 |
B |
$15.00 |
$150,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating Officer |
• – – |
2015-12-17 |
4 |
D |
$90.00 |
$19,455,210 |
D/D |
(216,169) |
0 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating Officer |
• – – |
2015-12-17 |
4 |
D |
$90.00 |
$1,111,770 |
D/D |
(12,353) |
0 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating Officer |
• – – |
2015-12-09 |
4 |
OE |
$10.92 |
$100,000 |
D/D |
9,154 |
225,323 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating Officer |
• • – |
2014-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
48,744 |
48,744 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating Officer |
• • – |
2014-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
21,191 |
167,425 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Operating OfficerOfficer |
• • – |
2014-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
146,234 |
|
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
V.P., Regulatory Affairs |
• – – |
2008-04-01 |
4 |
D |
$2.35 |
$257,247 |
D/D |
(109,467) |
0 |
0 |
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
V.P., Regulatory Affairs |
• – – |
2007-12-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
70,000 |
109,467 |
0 |
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
V.P., Regulatory Affairs |
• – – |
2007-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
74,467 |
0 |
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
V.P., Regulatory AffairsOffice |
• – – |
2007-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,467 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
